The Challenge

Targeting where resistance occurs in the conventional outflow pathway can be hard. Addressing the trabecular meshwork alone, or isolating a single point, may not be enough.

This unique anatomy and the possibility of resistance occurring at any point, means you need a surgical option that addresses all three points.

Between 50-75% of resistance may be in the Trabecular Meshwork1,2,3

Up to 50% of resistance may be in Schlemm’s canal and the distal collector channels1,2,3

The Solution
Only OMNI® targets all three points of resistance.

Trabecular meshwork
titratable trabeculotomy


Schlemm’s canal


Collector channels

ONE MIGS device

TWO implant free procedures

THREE points of resistance

Learn More
Meet the next generation OMNI® Surgical System.
With OMNI® Surgical System, you can perform two implant-free procedures targeting three points of resistance with one intelligent device.
Two procedures in one
intelligently designed device.
The OMNI® Surgical System is a manually operated device indicated for the delivery of small amounts of viscoelastic fluid during ophthalmic surgery through a custom microcatheter. It is also indicated for the cutting of trabecular meshwork when a trabeculotomy is indicated.
With its unique implant-free approach, the OMNI® Surgical System lets you access Schlemm’s canal with the microcatheter through a single clear corneal incision. Intelligently engineered with an internal reservoir delivering a controlled amount of viscoelastic fluid.
Titratable Trabeculotomy
To address the trabecular meshwork as a point of resistance within the conventional outflow pathway, the OMNI® Surgical System lets you perform a titratable trabeculotomy customized to meet your surgical plan.
View live case of the
OMNI® Surgical System
Patient Selection
Female, 70 year old:
Blurry vision
  • VA 20/60 OD, 20/40 OS
  • OD: 2-3+ NSC, OS: 1+ NSC
  • History of glaucoma
  • Meds: Travaprost and Cosopt PF, QHS OU
  • IOP: 19 OD, 17 OS
  • Visual field loss
  • CD Ratio: OD 0.5, OS 0.5
Male, 72 years old:
Prior cataract surgery
  • VA 20/20 OD, 20/30 OS
  • Previous ocular history of POAG – on Combigan and Lumigan
  • IOP: 21 OD, 23 OS
  • OCT and visual fields reflect Evidence of progression of disease
  • CD Ratio: OD 0.7, OS 0.5
Reimbursement Information
Please download our Reimbursement Guide for OMNI® Surgical System Reimbursement Information

Upcoming Events

August 20-23, 2020
Women in Ophthalmology (WIO)
Amelia Island, FL
September 11-12, 2020
Kiawah Eye
Kiawah Island, SC
BMC Vision Summit
September 25-27, 2020
Philadelphia, PA
European Society of Cataract and Refractive Surgeons (ESCRS)
October 3-7, 2020
Amsterdam, Netherlands
October 16-18, 2020
New York, NY
Interventional Glaucoma Congress (IGC)
October 29-31, 2020
Chicago, IL
American Academy of Ophthalmology
November 14-17, 2020
Las Vegas, NV
See Full list See Less list


Request more info about the OMNI® Surgical System

Are you a Cataract surgeon?*

Are you MIGS trained?*

Are you a Glaucoma specialist?*

Do you provide post-op care?*